Azeco Cosmeceuticals

4. References

1. Gollnick H, Layton A. Azelaic acid 15% gel in the treatment of rosacea. Exper Opin Pharmacother. 2008;9:2699-2706. 2. Del Rosso JQ, Bhatia N. Azelaic acid gel 15% in the management of papulopustular rosacea: a status report on available efficacy data and clinical application. Cutis. 2011; 88: 67-72. 3. Nazzaro-Porro, M., Passi, S., Morpurgo, G . & Breathnach, A. (1979a) Identification of tyrosinase inhibitors in cultures ai Pityrosporum and their melanocytotoxic effect. In: Pigment cell 4: Biologic basis of pigmemation (Ed. By S.N.Klaus), p. 234. S. Karger, Basel. 4. Nazzaro-Porro, M., Passi, S., Balus, S., Breathnach, A., Martin, B. & Morpurgo, G. {1979b) Effect of dicarboxylic acids on lentigo maligna. Journal of Investigative Dermatology, 72, 296. 5. Shin, J.W.; Park, K.C. Current clinical use of depigmenting agents. Dermatol Sin. 2014, 32, 205–210. 6. Nazzaro-Porro M, Passi S (1978) Identification of tyrosinase inhibitors in cultures of Pityrosporum. J Invest Dermatol 71:205–208. 7. Lowe, N.J.; Rizk, D.; Grimes, P.; Billips, M.; Pincus, S. Azelaic acid 20% cream in the treatment of facial hyperpigmentation in darker-skinned patients. Clin. Ther. 1998, 20, 945–959. 8. Webster, G. Combination azelaic acid therapy for acne vulgaris. J. Am. Acad. Dermatol. 2000, 43, S47–S50. 9. Draelos, Z. Multiple mechanisms of action of azelaic acid: New findings. J. Am. Acad. Dermatol. 2009, 60, AB86. 10. Baliña LM, Graupe K., Int. J. Dermatol. 1991 Dec; 30(12):893-5. 11. Couteau C., Coiffard L., Cosmetics, Overview of Skin Whitening Agents: Drugs and Cosmetic Products, July 2016. 12. Scarpa, A.; Guerci, A. Depigmenting procedures and drugs employed by melanoderm populations. J. Ethnopharmacol. 1987, 19, 17–66. 13. Kamagaju, L.; Bizuru, E.; Minani, V.; Morandini, R.; Stévigny, C.; Ghanem, G.; Duez, P. An ethnobotanical survey of medicinal plants used in Rwanda for volun- tary depigmentation. J. Ethnopharmacol. 2013, 150, 708–717. 14. Fiori, F.; Andrisano, V. LC–MS method for the simultaneous determination of six glucocorticoids in pharmaceutical formulations and counterfeit cosmetic pro- ducts. J. Pharm. Biomed. Anal. 2014, 91, 185–192. 15. Perry, A.; Petit, A.; Bagot, M.; Villa, A.; Bellaiche, M.; Bourrat, E. Intoxication au mercure par procuration chez un enfant: Une nouvelle complication de la dépigmentation volontaire. Arch. Pédiatr. 2014, 21, 22–24. 16. Sène, D.; Huong-Boutin, D.L.T.; Thiollet, M.; Barete, S.; Cacoub, P.; Piette, J.C. Insuffisance surrénalienne haute symptomatique compliquant l’usage de der - mocorticoïdes pour dépigmentation volontaire. Rev. Méd. Int. 2008, 29, 1030–1033. (In French) [CrossRef] [PubMed] 17. Porcheron, A.; Latreille, J.; Jdid, R.; Tschachler, E.; Morizot, F. Influence of skin ageing features on Chinese women’s perception of facial age and attractiveness. Int. J. Cosmet. Sci. 2014, 36, 312–320. 18. Pathak, M.; Fitzpatrick, T.B.; Kraus, E.W. Usefulness of retinoic acid in the treatment of melasma. J. Am. Acad. Dermatol. 1986, 15, 894–899. 19. Shin, J.W.; Park, K.C. Current clinical use of depigmenting agents. Dermatol Sin. 2014, 32, 205–210. [CrossRef] 20. Nazzaro-Porro, M. Azelaic acid. J. Am. Acad. Dermatol. 1987, 17, 1033–1041. 21. Mingrone, G.; Greco, A.V.; Ciardiello, A.; Passo, S.; Nazzaro-Porro, M. Distribution of radiolabelled azelaic acid in eye membranes and fluids of rabbits. Exp. Pathol. 1984, 25, 85–88. 22. Rossi A.B., Nocera T., Lapalud P., Study sponsored by Pierre Fabre Dermo-Cosmétique, Poster presented at AAD Meeting –Washington DC., March 4-8, 2016; 23. W.Ahmad, M.F.Haque, V.Brancolini, H.C.Tsou, S.Haque, H.M.Lam,V.M.Aita, J.Owen, M.deBlaquiere, J.A.Frank, P.B.Cserhalmi-Friedman, A.Leask, J.McGrath, M.Peacocke, M.Ahmad, J.Ott, A.M.Christiano, Alopecia Universalis Associated with a Mutation in the Human hairless Gene, Science 279,720,(1998). 24. http://www.americanhairloss.org/hair_loss_research/introduction.asp. 25. P.R. Pennycuik, K.A. Raphael, the angora locus go) in the mouse: hair morphology, duration of growth cycle and site of action. Genet.Res. 44,283,(1984). 26. J.P.Sundberg, H.Peters, Cyclic alopecia in Msx2 mutants: defects in hair cycling and hair shaft differentiation, Development 130,379,(2003). 27. J.M.Hébert, T.Rosenquist, J.Götz, G.R.Martin, FGF5 as a regulator of the hair growth cycle: evidence from targeted and spontaneous mutations, Cell 78,1017,(1994).

Phone : 0031475 782540 • info@azeco-cosmeceuticals.com • www.azeco-cosmeceuticals.com

30